Inorganic Nanomaterials as Carriers for Drug Delivery.
For safe and effective therapy, drugs must be delivered efficiently and with minimal systemic side effects. Nanostructured drug carriers enable the delivery of small-molecule drugs as well as nucleic acids and proteins. Inorganic nanomaterials are ideal for drug delivery platforms due to their unique physicochemical properties, such as facile preparation, good storage stability and biocompatibility. Many inorganic nanostructure-based drug delivery platforms have been prepared. Although there are still many obstacles to overcome, significant advances have been made in recent years. This review focuses on the status and development of inorganic nanostructures, including silica, quantum dots, gold, carbon-based and magnetic iron oxide-based nanostructures, as carriers for chemical and biological drugs. We specifically highlight the extensive use of these inorganic drug carriers for cancer therapy. Finally, we discuss the most important areas in the field that urgently require further study.
Shizhu
S
Chen
Xiaohong
X
Hao
Xingjie
X
Liang
Qun
Q
Zhang
Cuimiao
C
Zhang
Guoqiang
G
Zhou
Shigang
S
Shen
Guang
G
Jia
Jinchao
J
Zhang
D004339:Drug Compounding / Q000379:methods; D007287:Inorganic Chemicals / Q000737:chemistry*; D053768:Metal Nanoparticles / Q000737:chemistry* / Q000648:ultrastructure*; D053769:Nanocapsules / Q000737:chemistry* / Q000648:ultrastructure*; D012822:Silicon Dioxide / Q000737:chemistry*
D007287:Inorganic Chemicals; D053769:Nanocapsules; D012822:Silicon Dioxide